STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR
STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR
批准号:
6522994
负责人:
ZHAO-HUI SONG
金额:
$10.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2004-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Abstract)
The overall purpose of this research proposal is to identify the molecular
basis underlying the functions of the CB2 cannabinoid receptor. One of the
major problems for cannabinoids as therapeutic agents is their severe
psychoactive side-effect. The recent cloning of CB2, a subtype of
cannabinoid receptors, brought us new hope for a better medical use of
cannabinoids. CB2 is distributed primarily in the peripheral tissues,
whereas CB1 I distributed primary in the central nervous system. CB2 has
only 44 percent amino acid identity with CB1. Recently several
CB2-selective cannabinoid ligands have been discovered; the signal
transduction pathway for CB2 is being identified; and the pharmacological
properties of CB2 in a rat mast cell line, RBL-2H3 cells, have been shown to
be different from those of the cloned human CB2. The hypotheses of this
proposal include: 1. The ligand binding and signal transduction
characteristics of CB2 are determined by its unique structural features. 2.
The differences between RBL-2H3 cell cannabinoid receptors and human CB2 may
be explained by either the structural differences between rat and human CB2,
or the novel receptor subtypes that may exist in RBL-2H3 cells. The
following specific aims will attempt to test these hypotheses:
Specific Aim 1: To determine the amino acids of CB2 that are
important
for ligand binding.
Specific Aim 2: To determine the amino acids of CB2 that are
important
for receptor activation.
Specific Aim 3: To characterize cannabinoid receptor subtypes in a
rat
mast cell line (RBL-2H3). A combination of molecular cloning,
mutagenesis, heterologous expression, and pharmacological assays will be
utilized to test the hypotheses of this proposal. Molecular modeling
studies will be performed collaboratively. These studies should help us to
understand in more molecular detail the ligand binding and activation of
cannabinoid receptor subtypes, particularly about CB2, which is a very
important receptor for the immune-modulatory effects of marijuana and
cannabinoids. Ultimately, this may facilitate the development of novel
cannabinoid mimetics with improved therapeutic properties and minimized
psychoactive side effects.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility.
小梁网细胞中的 CB2 大麻素受体介导 JWH015 诱导的房水流出设施增强。
DOI:
10.1167/iovs.04-0651
发表时间:
2005
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[Zhong,Lichun, Geng,Lijun, Njie,Yafatou, Feng,Wenke, Song,Zhao-Hui]
通讯作者:
Song,Zhao-Hui
Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells.
小梁网细胞中 CB2 大麻素受体激活引起的分子和细胞变化。
DOI:
--
发表时间:
2007
期刊:
Molecular vision
影响因子:
2.2
作者:
[He,Fang, Song,Zhao-Hui]
通讯作者:
Song,Zhao-Hui
The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
电荷中和突变 D6.30N 对 CB1 和 CB2 大麻素受体功能的影响。
DOI:
10.1016/j.febslet.2006.09.001
发表时间:
2006
期刊:
FEBS letters
影响因子:
3.5
作者:
[Nebane,NtsangM, Kellie,Brandon, Song,Zhao-Hui]
通讯作者:
Song,Zhao-Hui
CB1 cannabinoid receptor-mediated changes of trabecular meshwork cellular properties.
CB1 大麻素受体介导的小梁网细胞特性变化。
DOI:
--
发表时间:
2006
期刊:
Molecular vision
影响因子:
2.2
作者:
[Kumar,Akhilesh, Song,Zhao-Hui]
通讯作者:
Song,Zhao-Hui
CB1 cannabinoid receptor-mediated cell migration.
CB1 大麻素受体介导的细胞迁移。
DOI:
--
发表时间:
2000
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
[Song,ZH, Zhong,M]
通讯作者:
Zhong,M
Endocannabinoid system as a therapeutic target for PVR
-
批准号:10747004
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2023
-
负责人:ZHAO-HUI SONG
-
依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
-
批准号:7655084
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2003
-
负责人:ZHAO-HUI SONG
-
依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
-
批准号:6774098
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2003
-
负责人:ZHAO-HUI SONG
-
依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
-
批准号:7895529
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2003
-
负责人:ZHAO-HUI SONG
-
依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
-
批准号:6923583
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2003
-
负责人:ZHAO-HUI SONG
-
依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
-
批准号:7095301
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2003
-
负责人:ZHAO-HUI SONG
-
依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
-
批准号:6681560
-
项目类别:
-
资助金额:$29.22万
-
财政年份:2003
-
负责人:ZHAO-HUI SONG
-
依托单位:
Structure and Function of CB2 Cannabinoid Receptor
-
批准号:7061327
-
项目类别:
-
资助金额:$25.12万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
Structure and Function of CB2 Cannabinoid Receptor
-
批准号:6886758
-
项目类别:
-
资助金额:$25.73万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
Structure and Function of CB2 Cannabinoid Receptor
-
批准号:7440803
-
项目类别:
-
资助金额:$4.04万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
Structure and Function of CB2 Cannabinoid Receptor
-
批准号:7222011
-
项目类别:
-
资助金额:$24.39万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
Structure and Function of CB2 Cannabinoid Receptor
-
批准号:6723452
-
项目类别:
-
资助金额:$25.71万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR
-
批准号:6378738
-
项目类别:
-
资助金额:$10.22万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR
-
批准号:6174723
-
项目类别:
-
资助金额:$9.92万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR
-
批准号:2694513
-
项目类别:
-
资助金额:$9.43万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR
-
批准号:2898218
-
项目类别:
-
资助金额:$9.54万
-
财政年份:1998
-
负责人:ZHAO-HUI SONG
-
依托单位:
海外基金